Drugs for HER-2-positive Breast Cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Sibilia, Maria (Editor ), Zielinski, Christoph C. (Editor ), Bartsch, Rupert (Editor ), Grunt, Thomas W. (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Basel :
Springer Basel : Imprint: Springer,
2011.
|
Edición: | 1st ed. 2011. |
Colección: | Milestones in Drug Therapy,
|
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance /
Publicado: (2013) -
Metastasis of Colorectal Cancer
Publicado: (2010) -
Mucosal Vaccines Modern Concepts, Strategies, and Challenges /
Publicado: (2012) -
Bispecific Antibodies
Publicado: (2011) -
Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications /
Publicado: (2013)